These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1095262)

  • 1. Effect of equivalent antihypertensive doses of mefruside and cyclopenthiazide on serum electrolytes, uric acid and glucose tolerance in hypertensive patients.
    Waal-Manning HJ
    Clin Exp Pharmacol Physiol; 1975; 2(2):141-6. PubMed ID: 1095262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of tienilic acid with cyclopenthiazide in hyperuricaemic hypertensive patients.
    Bolli P; Simpson FO; Waal-Manning HJ
    Lancet; 1978 Sep; 2(8090):595-8. PubMed ID: 80525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study comparing indapamide with cyclopenthiazide in geriatric patients.
    Khan AU
    Postgrad Med J; 1981; 57 Suppl 2():42-3. PubMed ID: 7033945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xipamide and cyclopenthiazide in essential hypertension--comparative effects on blood pressure and plasma potassium.
    MacGregor GA; Banks RA; Markandu ND; Roulston J
    Br J Clin Pharmacol; 1982 Jun; 13(6):859-63. PubMed ID: 7046777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension.
    Wray R; Benton KG; Whitehill D; Wright B; Weener W; Whittington JR
    Curr Med Res Opin; 1983; 8(9):665-74. PubMed ID: 6365467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of mefruside treatment in hypertension.
    Henningsen NC; Bergengren B; Malmborg O; Pihl O; Renmarker K; Strand L
    Acta Med Scand; 1980; 208(4):272-8. PubMed ID: 7446207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide.
    McVeigh G; Galloway D; Johnston D
    BMJ; 1988 Jul; 297(6641):95-8. PubMed ID: 3044503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the antihypertensive effects of indapamide and cyclopenthiazide.
    James I; Griffith D; Davis J; Wollard M; Waddell G
    Postgrad Med J; 1981; 57 Suppl 2():39-41. PubMed ID: 7322959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antihypertensive and metabolic effects of low and conventional dose cyclopenthiazide in type II diabetics with hypertension.
    Passmore AP; Whitehead EM; Crawford V; McVeigh GE; Johnston GD
    Q J Med; 1991 Nov; 81(295):919-28. PubMed ID: 1808632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The comparative effects of SE1520, frusemide, and cyclopenthiazide in healthy subjects.
    Leary WP; Asmal AC; Samuel P
    Curr Ther Res Clin Exp; 1973 Aug; 15(8):571-7. PubMed ID: 4200530
    [No Abstract]   [Full Text] [Related]  

  • 11. Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension.
    McVeigh GE; Dulie EB; Ravenscroft A; Galloway DB; Johnston GD
    Br J Clin Pharmacol; 1989 Apr; 27(4):523-6. PubMed ID: 2655692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary calcium excretion in treated and untreated essential hypertension.
    Quereda C; Orte L; Sabater J; Navarro-Antolin J; Villafruela JJ; Ortuño J
    J Am Soc Nephrol; 1996 Jul; 7(7):1058-65. PubMed ID: 8829122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of low versus conventional dose cyclopenthiazide on platelet intracellular calcium in mild essential hypertension.
    McVeigh GE; Copeland S; McKellar J; Johnston D
    J Hypertens; 1988 Apr; 6(4):337-41. PubMed ID: 3288695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the hypotensive effect of slow-release Trasicor].
    Cybulska I; Brym E
    Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of low dose diuretics on plasma and blood cell electrolytes, plasma uric acid and blood glucose.
    Sundberg S; Salo H; Gordin A; Melamies L; Lamminsivu U; Nuotto E; Keränen A
    Acta Med Scand Suppl; 1982; 668():95-101. PubMed ID: 6762810
    [No Abstract]   [Full Text] [Related]  

  • 16. One year follow-up of hyperuricaemic hypertensive patients treated with tienilic acid or a diuretic with or without uric acid-lowering drugs.
    Waal-Manning HJ; Simpson FO
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():379s-382s. PubMed ID: 396085
    [No Abstract]   [Full Text] [Related]  

  • 17. Studies on tienilic acid in hypertensive hyperuricaemic patients in Dunedin, New Zealand.
    Waal-Manning HJ; Bolli P; Wood AJ; Simpson FO
    Postgrad Med J; 1979; 55 Suppl 3():85-91. PubMed ID: 388401
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of mefruside on plasma and muscle electrolytes and blood pressure in normal subjects and in patients with essential hypertension.
    Bergström J; Hultman E; Solheim SB
    Acta Med Scand; 1973 Nov; 194(5):427-33. PubMed ID: 4757222
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of cyclothiazide and hydrochlorthiazide in hypertension. Effects of different doses of diuretics.
    Jounela AJ; Juustila H; Lilja M
    Cor Vasa; 1985; 27(6):412-6. PubMed ID: 3912112
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
    Gyntelberg F; Jacobsen K; Martlev A; Backer P
    Ugeskr Laeger; 1977 Mar; 139(11):641-6. PubMed ID: 320734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.